Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

RENE.L (RENE) Share News

12

IN BRIEF: ReNeuron administrators in talks with potential investors

17th May 2024 19:59

ReNeuron Group PLC - Brigdend, Wales-based stem cell and exosomes technology company - Says Mark Smith and Stephen Cork of Cork Gully LLP, joint administrators, issue statement of proposals to the members and creditors of the group. The joint administrators say they have identified potential cornerstone investors. Talks are currently progressing with the potential investors. Joint administrators say they have cut costs by shedding staff. Joint administrators also send "teaser document" to 749 potentially interested parties. Joint administrators are currently negotiating and having positive discussions with multiple parties in relation to their interest in the business and/or assets of the group. Read More

TRADING UPDATES: PetroTal buys Peru's Block 131 for USD5.0 million

17th May 2024 18:55

(Alliance News) - The following is a round-up of updates by London-listed companies, issued last week Wednesday and not separately reported by Alliance News: Read More

ReNeuron CFO steps down to pursue other opportunities

17th Apr 2024 11:58

(Alliance News) - ReNeuron Group PLC on Wednesday announced Chief Financial Officer John Hawkins will be stepping down from his role on May 7. Read More

TRADING UPDATES: ReNeuron appoints administrators as rescue talks fail

20th Mar 2024 18:11

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Wednesday and not separately reported by Alliance News: Read More

TRADING UPDATES: ReNeuron warns; Gama Aviation pledges cash return

5th Feb 2024 20:23

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Monday and not separately reported by Alliance News: Read More

ReNeuron interim loss narrows on lower costs; eyes partnerships

8th Nov 2023 12:21

(Alliance News) - ReNeuron Group PLC on Wednesday reported a slight narrowing in interim loss as costs decreased, as it highlighted its focus on its exosome delivery platform. Read More

IN BRIEF: ReNeuron makes progress on exosome delivery platform

4th Sep 2023 10:24

ReNeuron Group PLC - Brigend, Wales-based stem cell and exosomes technology company - Generates in vivo data to exemplify cellular and tissue targeting capabilities of exosomes, produced from its multiple conditionally immortalised producer cell lines. Exosomes are extracellular vesicles which carry nucleic acids, proteins, lipids and metabolites. Typically, they play important roles in immune response, tumour progression, and neurodegenerative diseases. Read More

UK shareholder meetings calendar - next 7 days

15th Aug 2023 15:45

Read More

UK earnings, trading statements calendar - next 7 days

18th May 2023 15:03

Read More

IN BRIEF: ReNeuron reduces headcount by 40%; to focus on CustomEX data

19th Jan 2023 14:29

ReNeuron Group PLC - Bridgend, Wales-based stem cell and exosomes technology company - Says it has reduced its headcount by 40% following company restructuring. The company says variable costs of the business have been lowered, with the resulting cash runway now extending to 2024. ReNeuron says its focus is generating in vivo data to validate its exosome delivery technology platform, CustomEx. CustomEx is a drug delivery platform which can be optimised for specific tissue targets leading to improvements in outcome for the patient. Read More

ReNeuron Chair Iain Ross moves to executive chair as CEO departs

3rd Jan 2023 11:21

(Alliance News) - ReNeuron Group PLC on Tuesday said its chief executive officer has left immediately, replaced by an executive chair. Read More

LONDON BRIEFING: Stocks called higher; China factory sector shrinks

3rd Jan 2023 07:58

(Alliance News) - Stocks in London are expected to start a new year on the front foot on Tuesday, after a mixed session in Asia amid weak Chinese economic data. Read More

AIM WINNERS & LOSERS: Orosur Mining drops on disappointing assays

2nd Dec 2022 10:40

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Friday. Read More

ReNeuron loss narrows amid lower costs and surging revenue

2nd Dec 2022 09:31

(Alliance News) - ReNeuron Group PLC on Friday said its loss narrowed in the first half of its financial year, following lower costs, increased revenue and foreign exchange gains. Read More

ReNeuron says exosomes outperform alternatives at Boston summit

7th Oct 2022 10:32

(Alliance News) - ReNeuron Group PLC on Friday said it presented positive new data at a leading summit of targeted therapies. Read More

IN BRIEF: ReNeuron promotes Financial Controller Hawkins to CFO

14th Sep 2022 13:19

ReNeuron Group PLC - Bridgend, Wales-based stem cell and exosomes technology company - Promotes Financial Controller John Hawkins to chief financial officer with immediate effect. Hawkins joined the company in 2014 as financial controller and was also named as the company secretary last year. Says Hawkins is an experienced finance professional with a breadth of experience gained within "a variety of businesses, from large PLCs to family-owned SMEs". Read More

UK shareholder meetings calendar - next 7 days

2nd Sep 2022 15:57

Read More

EXECUTIVE CHANGES: ReNeuron promotes CFO Catherine Isted to CEO role

1st Aug 2022 14:30

(Alliance News) - The following is a round-up of London-listed company director and manager changes announced on Monday and not separately reported by Alliance News: Read More

IN BRIEF: ReNeuron annual loss narrows amid shift in strategy

4th Jul 2022 10:22

ReNeuron Group PLC - Bridgend, Wales-based stem cell and exosomes technology company - Pretax loss in year to March 31 narrows to GBP11.1 million from GBP13.4 million loss a year prior. Research & development costs fall to GBP8.1 million from GBP9.5 million, with general & administrative costs at GBP3.6 million versus GBP3.7 million. Revenue drops to GBP403,000 from GBP257,000. Read More

IN BRIEF: ReNeuron inks deal worth up to GBP6 million in revenue

1st Jul 2022 13:40

ReNeuron Group PLC - Bridgend, Wales-based stem cell and exosomes technology company - Negotiates a supplemental terms agreement with Shanghai Fosun Pharmaceutical Group Co Ltd. Company says the agreement has the potential to generate revenue of up to GBP6 million. Read More

12
FTSE 100 Latest
Value8,809.74
Change53.53